The support is up significantly from last year, when more than 95 health care organizations signaled their support in similar letters to the House and Senate last September.
HB2190, which passed 81-8, amends the states medical marijuana guidelines to require medical marijuana dispensaries to appoint a pharmacist consultant who, would develop and provide training to the dispensary at least once a year and spearhead educational efforts for patients.
If approved, former FDA Deputy Commissioner Scott Gottlieb would make streamlining drug approvals his top priority.
Genentech’s Ocrevus (ocrelizumab) is used to treat adult patients with relapsing forms of multiple sclerosis and primary progressive multiple sclerosis.
QuickFire Challenge winners will receive grants totaling up to $200,000, entrance to a Johnson & Johnson Innovation – JLABS facility and/or mentoring from Johnson & Johnson Innovation.
As part of the investment higi has acquired EveryMove, a pioneer in consumer health engagement that delivers incentives to health plan members to reduce costs and improve outcomes.
Regeneron’s Dupixent is intended for patients whose eczema is not controlled adequately by topical therapies, or those for whom topical therapies are not advisable.
Oxycodone APAP Tablets are available in 2.5/325mg, 5/325mg, 7.5/325mg and 10/325mg — 100- and 500-count bottles and are anticipated to ship in the second quarter.
ORIEN Avatar fosters collaboration among key stakeholders in cancer research with the shared goal of discovering and developing novel therapies in clinical trials.